Adherence to Integrative Care, Oncology Healthcare Utilization, Opioid Use and Hospitalization
Integrative Cancer Therapies · 2025
DOI: 10.1177/15347354251387955 ↗Kurz gefasst
Fachartikel in der Zeitschrift Integrative Cancer Therapies, 2025. Verfasst von Eran Ben-Arye und 4 weiteren Autor:innen. Beteiligte Einrichtung: Integrative Oncology Program, The Oncology Service; Lin, Carmel, and Zebulun Medical centers, Clalit Health Services, Haifa, Israel. Hauptthemen laut MEDLINE: Hospitalization, Neoplasms, Analgesics, Opioid, Integrative Oncology. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Research on the relationship between integrative oncology (IO) programs and dispensing of chemotherapy agents and supportive care drugs, and hospitalization rates is limited. The present study examined these outcomes in chemotherapy-treated patients with cancer, comparing patients highly adherent to integrative care (high-AIC) to those with low adherence (low-AIC). Data from patients with cancer treated with taxane and/or platinum-based agents participating in an ongoing prospective, controlled pragmatic trial were examined retrospectively. Patients were referred to an IO consultation and weekly treatments at 3 medical centers in Northern Israel, with high-AIC defined as attending ≥4 sessions at 6 weeks; low-AIC, 0-3 sessions. Cancer-related parameters; dispensing of medication (chemotherapy agents, analgesics, anxiolytics and opioids); rates of hospitalizations and emergency room visits were analyzed using generalized linear regression models. Of 615 patients attending the IO consultation, 367 (59.7%) were high-AIC, with both groups having mostly similar baseline characteristics. Dispensing rates for taxanes ( P = .336), platinum agents ( P = .403), non-opioid analgesics ( P = .201), and anxiolytics ( P = .350), and number of emergency room visits were similar in both groups at 12 weeks. However, high-AIC patients had fewer dispensed opioid prescriptions (RR = 0.50, 95% CI = 0.30-0.85, P = .010); lower rates of hospitalization (OR = 0.59, 95% CI = 0.39-0.88, P = .010); and fewer hospitalization days (RR = 0.53, 95% CI = 0.31-0.90, P = .019). In conclusion, dispensing of chemotherapy drugs was similar between groups, though high-AIC patients used less opioids and had fewer hospitalizations at 12 weeks. Further research is needed with randomized and prospective studies exploring the relationship between adherence to IO care; adherence to chemotherapy; quality of life; opioid use; and hospitalization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Integrative Oncology Program, The Oncology Service; Lin, Carmel, and Zebulun Medical centers, Clalit Health Services, Haifa, Israel.
- Ruth and Bruch Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
- Department of Health Policy and Management, Guilford Glazer Faculty of Business and Management and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
- Center for Integrative Complementary Medicine, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel.
- Sidney Kimmel Medical College and Sydney Kimmel comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
ORCID-Profile: Eran Ben-Arye
Zitieren
APA
Ben-Arye, E., Greenberg, D., Samuels, N., Lopez, A. M., & Simon-Tuval, T. (2025). Adherence to Integrative Care, Oncology Healthcare Utilization, Opioid Use and Hospitalization. Integrative Cancer Therapies. https://doi.org/10.1177/15347354251387955
Vancouver
Ben-Arye E, Greenberg D, Samuels N, Lopez AM, Simon-Tuval T. Adherence to Integrative Care, Oncology Healthcare Utilization, Opioid Use and Hospitalization. Integrative Cancer Therapies. 2025. doi:10.1177/15347354251387955
BibTeX
@article{BenArye2025,
author = {Ben-Arye, Eran and Greenberg, Dan and Samuels, Noah and Lopez, Ana Maria and Simon-Tuval, Tzahit},
title = {Adherence to Integrative Care, Oncology Healthcare Utilization, Opioid Use and Hospitalization},
journal = {Integrative Cancer Therapies},
year = {2025},
doi = {10.1177/15347354251387955}
}
EUVIMED